Shrestha Shristi, Agha Raafae S, Khan Zershana, Shah Kaushal, Jain Shailesh
Psychiatry, Texas Tech University Health Sciences Center, Midland, USA.
Psychiatry, Griffin Memorial Hospital, Norman, USA.
Cureus. 2021 Jan 26;13(1):e12919. doi: 10.7759/cureus.12919.
This case series highlights the importance of loxapine in psychiatric disorders when clozapine is unable to control agitation and psychotic symptoms due to medication noncompliance, intolerable side effects, or inadequate clinical outcomes. Loxapine is classified as a first-generation typical antipsychotic but displays atypical antipsychotic-like characteristics with structural similarity to clozapine. However, since the inception of second-generation antipsychotic medications, the role of loxapine in modern psychiatric practice has become limited. Loxapine has been underutilized due to concerns of side effects and lack of in-depth research about its safety, tolerability, and efficacy. This report revisits loxapine's clinical utility through two well-studied long-term inpatient cases, where it played a crucial role in controlling psychotic symptoms and achieving better medication compliance by eliminating significant barriers, including monitoring regular differential complete blood counts. We aim to add to the current evidence and literature about the advantage of using loxapine for specific clinical scenarios in psychiatric practice.
本病例系列强调了洛沙平在精神疾病中的重要性,当氯氮平因患者不遵医嘱、无法耐受的副作用或临床疗效不佳而无法控制激越和精神病性症状时,洛沙平可发挥作用。洛沙平被归类为第一代典型抗精神病药物,但具有非典型抗精神病药物样的特征,其结构与氯氮平相似。然而,自第二代抗精神病药物问世以来,洛沙平在现代精神科实践中的作用变得有限。由于担心副作用以及缺乏对其安全性、耐受性和疗效的深入研究,洛沙平一直未得到充分利用。本报告通过两个经过充分研究的长期住院病例重新审视了洛沙平的临床效用,在这两个病例中,洛沙平在控制精神病性症状以及通过消除包括定期监测全血细胞计数差异等重大障碍来提高药物依从性方面发挥了关键作用。我们旨在为目前关于在精神科实践中特定临床场景使用洛沙平的优势的证据和文献增添内容。